CURN.SW Stock — Price, Charts & Analysis

Curatis Holding AG (CURN.SW) has no trailing P/E shown and a forward P/E of 41.46x. This places CURN.SW in a premium earnings multiple territory based on the valuation data currently available on Worldtickers.

CURN.SW trades with 41.46x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether CURN.SW looks overvalued or undervalued.

CURN.SW's P/E of 41.46x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

CURN.SW's trailing EPS is -CHF 0.28 and forward EPS is CHF 0.48.

EPS, or earnings per share, shows how much profit Curatis Holding AG generated for each share. CURN.SW's trailing EPS is -CHF 0.28, and investors usually prefer EPS that is positive and growing over time.

Curatis Holding AG has a market cap of CHF 105.49M, making CURN.SW a small-cap stock based on the current market value shown on Worldtickers.

CURN.SW's latest stock price on Worldtickers is CHF 19.90. The latest move is -CHF 0.05 or -0.25%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

CURN.SW's quote includes a latest price of CHF 19.90. The market open is CHF 19.65. Previous close is CHF 19.95. The intraday range is CHF 19.40 to CHF 19.90.

CURN.SW is down in the latest quote, with a move of -CHF 0.05 or -0.25%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

CURN.SW generated CHF 10.80M in trailing revenue. Revenue growth is 13.00%, which helps show whether demand is expanding or slowing.

CURN.SW's revenue growth is 13.00%, which is a strong demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

No, CURN.SW does not show positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is -CHF 1.42M.

Gross margin is 26.31%. Margins show how efficiently Curatis Holding AG turns revenue into profit.

Curatis Holding AG carries CHF 0.00 and holds CHF 1.87M in cash.

CURN.SW holds CHF 1.87M on its balance sheet.

CURN.SW's book value per share is CHF 8.94.

Institutions hold 0.75% of CURN.SW shares. Insiders hold 78.09% of shares. Ownership mix helps investors understand how much of Curatis Holding AG is held by professional investors and company insiders.

CURN.SW has 5.3M shares outstanding. Float shares are 1.13M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for CURN.SW, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for CURN.SW is CHF 0.48. Revenue growth is 13.00%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

CURN.SW's trailing EPS is -CHF 0.28. Forward EPS is CHF 0.48. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

CURN.SW is in the Healthcare sector. Its earnings multiple is 41.46x. Its latest displayed growth metric is 13.00%. Compare these figures with sector peers before deciding whether Curatis Holding AG is stronger or weaker than average.

CURN.SW trades at CHF 19.90. The stock trades at 41.46x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Curatis Holding AG's fundamentals.

CURN.SW risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is -0.79, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

CURN.SW should be compared with companies in Drug Manufacturers - Specialty & Generic. Its earnings multiple is 41.46x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Curatis Holding AG (CURN.SW) operates in Healthcare, specifically Drug Manufacturers - Specialty & Generic. Curatis Holding AG engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases. It offers its products in the areas of fentanyl, breakthrough pain, antiplatelet, metastatic hormone receptor-positive breast cancer, anti-arrhythmic, nasal oil, wilson's disease, cyanide poisoning, digoxin toxicity, antihypotensive, bladder pain syndrome/intersticial cystitis, antibioticum, diagnostic ophthalmology, antiviral, ophtalmic/ an

CURN.SW trades on Swiss. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

CURN.SW stock is priced in CHF on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Curatis Holding AG's official website listed on Worldtickers is curatis.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Curatis Holding AG employs about 9 people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

Curatis Holding AG is headquartered in Liestal, Switzerland. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

CURN.SW is in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

CURN.SW has traded between CHF 10.90 and CHF 27.90 over the past 52 weeks. At CHF 19.90, it is 28.67% below the high and 82.57% above the low. The 52-week range helps gauge long-term price momentum.

CURN.SW is between its 50-day and 200-day moving averages, which suggests a mixed trend setup. Its 50-day moving average is CHF 22.17 and its 200-day moving average is CHF 19.15.

CURN.SW's RSI is 43.87. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

CURN.SW's latest RSI reading is 43.87, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for CURN.SW is near CHF 18.00. Key resistance is near CHF 23.90. Breaks above resistance or below support can change the short-term technical setup.

CURN.SW's nearest reported support level is CHF 18.00. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

CURN.SW's nearest reported resistance level is CHF 23.90. A breakout above resistance can improve momentum, especially when volume confirms the move.

CURN.SW trades about 2.76K shares daily on average. The latest displayed volume is 783 shares. Volume helps show liquidity and whether trading interest is unusually high or low.

CURN.SW's MACD is 0.04, which is a positive momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

CURN.SW is between its 50-day and 200-day moving averages, which suggests a mixed trend setup. RSI is 43.87 (neutral). MACD is bullish. Nearest support is around CHF 18.00. Resistance is around CHF 23.90. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is CHF 20.47 (-2.77% from price). MA50 is CHF 22.17 (-10.22% from price). MA200 is CHF 19.15 (3.94% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. CURN.SW's MA20 is CHF 20.47. MA50 is CHF 22.17. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

CURN.SW's pivot is near CHF 19.82. Support is near CHF 18.00. Resistance is near CHF 23.90. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for CURN.SW is near CHF 18.00. The next upper resistance zone is near CHF 20.65. These levels help define risk and possible follow-through zones after a breakout or breakdown.

CURN.SW's Bollinger range is roughly CHF 17.53 to CHF 23.40. Band width is near 28.68%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

CURN.SW's ATR-based typical daily range is about 4.60%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 783 shares. Average volume is about 2.76K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

CURN.SW's all-time high shown on Worldtickers is CHF 3,942,399.80. Its all-time low is CHF 0.90. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

CURN.SW has a beta of -0.79, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.